HEADER HYDROLASE/HYDROLASE INHIBITOR 06-DEC-13 4NWK
TITLE CRYSTAL STRUCTURE OF HEPATIS C VIRUS PROTEASE (NS3) COMPLEXED WITH
TITLE 2 BMS-605339 AKA N-(TERT-BUTOXYCARBONYL)-3-ME THYL-L-VALYL-(4R)-N-((1R,
TITLE 3 2S)-1-((CYCLOPROPYLSULFONYL)CARBA MOYL)-2-VINYLCYCLOPROPYL)-4-((6-
TITLE 4 METHOXY-1-ISOQUINOLINYL)OX Y)-L-PROLINAMIDE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: HCV NS3 1A PROTEASE;
COMPND 3 CHAIN: A;
COMPND 4 ENGINEERED: YES;
COMPND 5 OTHER_DETAILS: THE PROTEIN CRYSTALLIZED IS A SINGLE-CHAIN CONSTRUCT
COMPND 6 OF PROTEASE DOMAIN OF HEPATITIS C VIRUS NS3/4A, WITH COFACTOR 4A
COMPND 7 COVALENTLY LINKED AT THE N-TERMINUS.
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS;
SOURCE 3 ORGANISM_TAXID: 31646;
SOURCE 4 STRAIN: 1A;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS HYDROLASE/HYDROLASE INHIBITOR, SERINE PROTEASE, HYDROLASE-HYDROLASE
KEYWDS 2 INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR J.K.MUCKELBAUER,H.E.KLEI
REVDAT 3 28-FEB-24 4NWK 1 REMARK SEQADV LINK
REVDAT 2 09-AUG-17 4NWK 1 SOURCE
REVDAT 1 26-MAR-14 4NWK 0
JRNL AUTH P.M.SCOLA,A.X.WANG,A.C.GOOD,L.Q.SUN,K.D.COMBRINK,
JRNL AUTH 2 J.A.CAMPBELL,J.CHEN,Y.TU,N.SIN,B.L.VENABLES,S.Y.SIT,Y.CHEN,
JRNL AUTH 3 A.COCUZZA,D.M.BILDER,S.D'ANDREA,B.ZHENG,P.HEWAWASAM,M.DING,
JRNL AUTH 4 J.THURING,J.LI,D.HERNANDEZ,F.YU,P.FALK,G.ZHAI,A.K.SHEAFFER,
JRNL AUTH 5 C.CHEN,M.S.LEE,D.BARRY,J.O.KNIPE,W.LI,Y.H.HAN,S.JENKINS,
JRNL AUTH 6 C.GESENBERG,Q.GAO,M.W.SINZ,K.S.SANTONE,T.ZVYAGA,R.RAJAMANI,
JRNL AUTH 7 H.E.KLEI,R.J.COLONNO,D.M.GRASELA,E.HUGHES,C.CHIEN,S.ADAMS,
JRNL AUTH 8 P.C.LEVESQUE,D.LI,J.ZHU,N.A.MEANWELL,F.MCPHEE
JRNL TITL DISCOVERY AND EARLY CLINICAL EVALUATION OF BMS-605339, A
JRNL TITL 2 POTENT AND ORALLY EFFICACIOUS TRIPEPTIDIC ACYLSULFONAMIDE
JRNL TITL 3 NS3 PROTEASE INHIBITOR FOR THE TREATMENT OF HEPATITIS C
JRNL TITL 4 VIRUS INFECTION.
JRNL REF J.MED.CHEM. V. 57 1708 2014
JRNL REFN ISSN 0022-2623
JRNL PMID 24555570
JRNL DOI 10.1021/JM401840S
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH H.E.KLEI,K.KISH,M.F.RUSSO,S.J.MICHALCZYK,M.H.CAHN,J.TREDUP,
REMARK 1 AUTH 2 C.CHANG,J.KHAN,E.T.BALDWIN
REMARK 1 TITL IMAGE ANNOTATION AND DATABASE MINING TO CREATE A NOVEL
REMARK 1 TITL 2 SCREEN FOR THE CHEMOTYPE-DEPENDENT CRYSTALLIZATION OF HCV
REMARK 1 TITL 3 NS3 PROTEASE
REMARK 1 REF CRYST. GROWTH AND DES. V. 11 1143 2011
REMARK 2
REMARK 2 RESOLUTION. 1.62 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.14
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 480513.000
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.5
REMARK 3 NUMBER OF REFLECTIONS : 26144
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.199
REMARK 3 R VALUE (WORKING SET) : 0.198
REMARK 3 FREE R VALUE : 0.213
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.900
REMARK 3 FREE R VALUE TEST SET COUNT : 1017
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA.
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.1990
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.1980
REMARK 3 FREE R VALUE (NO CUTOFF) : 0.213
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 3.900
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1023
REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0070
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 26331
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 8
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.67
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 61.20
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1973
REMARK 3 BIN R VALUE (WORKING SET) : 0.2270
REMARK 3 BIN FREE R VALUE : 0.2110
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 99
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 1391
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 98
REMARK 3 SOLVENT ATOMS : 202
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 12.40
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.78
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.07000
REMARK 3 B22 (A**2) : -1.01000
REMARK 3 B33 (A**2) : 1.08000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18
REMARK 3 ESD FROM SIGMAA (A) : 0.08
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.19
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.05
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.007
REMARK 3 BOND ANGLES (DEGREES) : 1.700
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.20
REMARK 3 IMPROPER ANGLES (DEGREES) : 1.340
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 0.980 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.440 ; 2.000
REMARK 3 SIDE-CHAIN BOND (A**2) : 1.980 ; 2.000
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.740 ; 2.500
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : FLAT MODEL
REMARK 3 KSOL : 0.42
REMARK 3 BSOL : 47.38
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARA
REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARA
REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 4 : ION.PARAM
REMARK 3 PARAMETER FILE 5 : LIGAND.PARAM
REMARK 3 PARAMETER FILE 6 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP
REMARK 3 TOPOLOGY FILE 2 : WATER.TOP
REMARK 3 TOPOLOGY FILE 3 : ION.TOP
REMARK 3 TOPOLOGY FILE 4 : LIGAND.TOP
REMARK 3 TOPOLOGY FILE 5 : NULL
REMARK 3 TOPOLOGY FILE 6 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 4NWK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JAN-14.
REMARK 100 THE DEPOSITION ID IS D_1000083745.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 18-FEB-04
REMARK 200 TEMPERATURE (KELVIN) : 100.0
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 32-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL
REMARK 200 DATA SCALING SOFTWARE : NULL
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26368
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.620
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0
REMARK 200 DATA REDUNDANCY : 5.800
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: NULL
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 34.29
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.87
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z
REMARK 290 3555 -X+1/2,Y+1/2,-Z
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 21.59850
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.92600
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.59850
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.92600
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A -14
REMARK 465 LYS A -13
REMARK 465 LYS A -12
REMARK 465 LYS A -11
REMARK 465 THR A 178
REMARK 465 MET A 179
REMARK 465 ARG A 180
REMARK 465 SER A 181
REMARK 465 PRO A 182
REMARK 465 ALA A 183
REMARK 465 ILE A 184
REMARK 465 ARG A 185
REMARK 465 ALA A 186
REMARK 465 PRO A 187
REMARK 465 SER A 188
REMARK 465 THR A 189
REMARK 465 SER A 190
REMARK 465 LEU A 191
REMARK 465 ARG A 192
REMARK 465 PRO A 193
REMARK 465 HIS A 194
REMARK 465 SER A 195
REMARK 465 SER A 196
REMARK 465 THR A 197
REMARK 465 THR A 198
REMARK 465 THR A 199
REMARK 465 THR A 200
REMARK 465 THR A 201
REMARK 465 THR A 202
REMARK 465 GLU A 203
REMARK 465 ILE A 204
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 THR A 38 -168.71 -106.94
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 ZN A 302 ZN
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 CYS A 97 SG
REMARK 620 2 CYS A 99 SG 125.2
REMARK 620 3 CYS A 145 SG 112.6 111.0
REMARK 620 N 1 2
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2R8 A 301
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 302
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 303
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 304
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 305
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 306
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 307
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC8
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 308
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC9
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 309
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 310
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 4NWL RELATED DB: PDB
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 THE COFACTOR 4A RESIDUES -10-0(GLY SER VAL VAL ILE VAL GLY ARG ILE
REMARK 999 ASN LEU) IN THIS ENTRY CORRESPOND TO RESIDUES NUMBERING 1678-1688
REMARK 999 OF DATABASE SEQUENCE REFERENCE (UNP A8DG50). THIS PEPTIDE IS
REMARK 999 COVALENTLY LINKED TO THE N-TERMINUS OF NS3 VIA LINKER (SER GLY ASP
REMARK 999 THR). C1679S MUTATION WAS ENGINEERED TO PREVENT DISULFIDE
REMARK 999 FORMATION. THE V1686I AND I1687N WERE ENGINEERED TO OPTIMIZE THE
REMARK 999 LINKER BETWEEN THE COFACTOR 4A AND NS3.
DBREF 4NWK A -10 0 UNP A8DG50 A8DG50_9HEPC 1678 1688
DBREF 4NWK A 5 182 UNP A8DG50 A8DG50_9HEPC 1035 1212
SEQADV 4NWK MET A -14 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK LYS A -13 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK LYS A -12 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK LYS A -11 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK SER A -9 UNP A8DG50 CYS 1679 SEE REMARK 999
SEQADV 4NWK ILE A -2 UNP A8DG50 VAL 1686 SEE REMARK 999
SEQADV 4NWK ASN A -1 UNP A8DG50 ILE 1687 SEE REMARK 999
SEQADV 4NWK SER A 1 UNP A8DG50 LINKER
SEQADV 4NWK GLY A 2 UNP A8DG50 LINKER
SEQADV 4NWK ASP A 3 UNP A8DG50 LINKER
SEQADV 4NWK THR A 4 UNP A8DG50 LINKER
SEQADV 4NWK GLU A 13 UNP A8DG50 LEU 1043 ENGINEERED MUTATION
SEQADV 4NWK GLU A 14 UNP A8DG50 LEU 1044 ENGINEERED MUTATION
SEQADV 4NWK GLN A 17 UNP A8DG50 ILE 1047 ENGINEERED MUTATION
SEQADV 4NWK GLU A 18 UNP A8DG50 ILE 1048 ENGINEERED MUTATION
SEQADV 4NWK GLN A 21 UNP A8DG50 LEU 1051 ENGINEERED MUTATION
SEQADV 4NWK THR A 40 UNP A8DG50 ALA 1070 ENGINEERED MUTATION
SEQADV 4NWK SER A 47 UNP A8DG50 CYS 1077 ENGINEERED MUTATION
SEQADV 4NWK LEU A 52 UNP A8DG50 CYS 1082 ENGINEERED MUTATION
SEQADV 4NWK THR A 72 UNP A8DG50 ILE 1102 ENGINEERED MUTATION
SEQADV 4NWK GLN A 86 UNP A8DG50 PRO 1116 ENGINEERED MUTATION
SEQADV 4NWK ALA A 183 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK ILE A 184 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK ARG A 185 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK ALA A 186 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK PRO A 187 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK SER A 188 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK THR A 189 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK SER A 190 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK LEU A 191 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK ARG A 192 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK PRO A 193 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK HIS A 194 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK SER A 195 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK SER A 196 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK THR A 197 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK THR A 198 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK THR A 199 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK THR A 200 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK THR A 201 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK THR A 202 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK GLU A 203 UNP A8DG50 EXPRESSION TAG
SEQADV 4NWK ILE A 204 UNP A8DG50 EXPRESSION TAG
SEQRES 1 A 219 MET LYS LYS LYS GLY SER VAL VAL ILE VAL GLY ARG ILE
SEQRES 2 A 219 ASN LEU SER GLY ASP THR ALA TYR ALA GLN GLN THR ARG
SEQRES 3 A 219 GLY GLU GLU GLY CYS GLN GLU THR SER GLN THR GLY ARG
SEQRES 4 A 219 ASP LYS ASN GLN VAL GLU GLY GLU VAL GLN ILE VAL SER
SEQRES 5 A 219 THR ALA THR GLN THR PHE LEU ALA THR SER ILE ASN GLY
SEQRES 6 A 219 VAL LEU TRP THR VAL TYR HIS GLY ALA GLY THR ARG THR
SEQRES 7 A 219 ILE ALA SER PRO LYS GLY PRO VAL THR GLN MET TYR THR
SEQRES 8 A 219 ASN VAL ASP LYS ASP LEU VAL GLY TRP GLN ALA PRO GLN
SEQRES 9 A 219 GLY SER ARG SER LEU THR PRO CYS THR CYS GLY SER SER
SEQRES 10 A 219 ASP LEU TYR LEU VAL THR ARG HIS ALA ASP VAL ILE PRO
SEQRES 11 A 219 VAL ARG ARG ARG GLY ASP SER ARG GLY SER LEU LEU SER
SEQRES 12 A 219 PRO ARG PRO ILE SER TYR LEU LYS GLY SER SER GLY GLY
SEQRES 13 A 219 PRO LEU LEU CYS PRO ALA GLY HIS ALA VAL GLY ILE PHE
SEQRES 14 A 219 ARG ALA ALA VAL CYS THR ARG GLY VAL ALA LYS ALA VAL
SEQRES 15 A 219 ASP PHE ILE PRO VAL GLU SER LEU GLU THR THR MET ARG
SEQRES 16 A 219 SER PRO ALA ILE ARG ALA PRO SER THR SER LEU ARG PRO
SEQRES 17 A 219 HIS SER SER THR THR THR THR THR THR GLU ILE
HET 2R8 A 301 50
HET ZN A 302 1
HET SO4 A 303 5
HET GOL A 304 6
HET GOL A 305 6
HET GOL A 306 6
HET GOL A 307 6
HET GOL A 308 6
HET GOL A 309 6
HET GOL A 310 6
HETNAM 2R8 N-(TERT-BUTOXYCARBONYL)-3-METHYL-L-VALYL-(4R)-N-{(1R,
HETNAM 2 2R8 2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-
HETNAM 3 2R8 ETHENYLCYCLOPROPYL}-4-[(6-METHOXYISOQUINOLIN-1-YL)
HETNAM 4 2R8 OXY]-L-PROLINAMIDE
HETNAM ZN ZINC ION
HETNAM SO4 SULFATE ION
HETNAM GOL GLYCEROL
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 2 2R8 C35 H47 N5 O9 S
FORMUL 3 ZN ZN 2+
FORMUL 4 SO4 O4 S 2-
FORMUL 5 GOL 7(C3 H8 O3)
FORMUL 12 HOH *202(H2 O)
HELIX 1 1 GLY A 12 GLY A 23 1 12
HELIX 2 2 TYR A 56 GLY A 60 1 5
HELIX 3 3 PRO A 131 LYS A 136 1 6
HELIX 4 4 GLU A 173 LEU A 175 5 3
SHEET 1 A 7 TYR A 6 GLN A 9 0
SHEET 2 A 7 VAL A -7 ASN A -1 -1 N ASN A -1 O TYR A 6
SHEET 3 A 7 VAL A 33 SER A 37 -1 O ILE A 35 N VAL A -5
SHEET 4 A 7 THR A 42 ILE A 48 -1 O ALA A 45 N GLN A 34
SHEET 5 A 7 VAL A 51 VAL A 55 -1 O TRP A 53 N THR A 46
SHEET 6 A 7 LEU A 82 GLN A 86 -1 O TRP A 85 N LEU A 52
SHEET 7 A 7 TYR A 75 ASN A 77 -1 N ASN A 77 O LEU A 82
SHEET 1 B 7 ASP A 103 VAL A 107 0
SHEET 2 B 7 VAL A 113 GLY A 120 -1 O VAL A 116 N LEU A 104
SHEET 3 B 7 ARG A 123 ARG A 130 -1 O ARG A 123 N ARG A 119
SHEET 4 B 7 VAL A 163 PRO A 171 -1 O VAL A 167 N GLY A 124
SHEET 5 B 7 ALA A 150 THR A 160 -1 N ALA A 156 O ASP A 168
SHEET 6 B 7 PRO A 142 LEU A 144 -1 N LEU A 143 O VAL A 151
SHEET 7 B 7 ASP A 103 VAL A 107 -1 N TYR A 105 O LEU A 144
LINK SG CYS A 97 ZN ZN A 302 1555 1555 2.27
LINK SG CYS A 99 ZN ZN A 302 1555 1555 2.18
LINK SG CYS A 145 ZN ZN A 302 1555 1555 2.38
SITE 1 AC1 25 GLN A 41 PHE A 43 HIS A 57 GLY A 58
SITE 2 AC1 25 ASP A 79 ASP A 81 HIS A 110 ASP A 112
SITE 3 AC1 25 ARG A 130 PRO A 131 ILE A 132 TYR A 134
SITE 4 AC1 25 LEU A 135 LYS A 136 GLY A 137 SER A 138
SITE 5 AC1 25 SER A 139 PHE A 154 ARG A 155 ALA A 156
SITE 6 AC1 25 ALA A 157 GOL A 305 GOL A 309 GOL A 310
SITE 7 AC1 25 HOH A 457
SITE 1 AC2 4 CYS A 97 CYS A 99 CYS A 145 HIS A 149
SITE 1 AC3 9 THR A 10 ARG A 11 GLY A 12 GLY A 15
SITE 2 AC3 9 ARG A 117 ARG A 119 HOH A 426 HOH A 450
SITE 3 AC3 9 HOH A 558
SITE 1 AC4 9 SER A 66 VAL A 71 GLN A 86 ALA A 87
SITE 2 AC4 9 PRO A 88 HOH A 417 HOH A 468 HOH A 476
SITE 3 AC4 9 HOH A 539
SITE 1 AC5 5 THR A 42 GLY A 137 2R8 A 301 GOL A 310
SITE 2 AC5 5 HOH A 458
SITE 1 AC6 9 GLY A 60 THR A 61 ARG A 62 PRO A 129
SITE 2 AC6 9 HOH A 437 HOH A 447 HOH A 469 HOH A 487
SITE 3 AC6 9 HOH A 494
SITE 1 AC7 5 THR A 22 GLY A 120 ASP A 121 SER A 122
SITE 2 AC7 5 HOH A 520
SITE 1 AC8 5 LEU A 0 GLY A 2 ASP A 3 ALA A 5
SITE 2 AC8 5 HOH A 547
SITE 1 AC9 6 SER A 133 TYR A 134 2R8 A 301 HOH A 432
SITE 2 AC9 6 HOH A 463 HOH A 561
SITE 1 BC1 9 GLN A 41 SER A 128 ARG A 130 LYS A 136
SITE 2 BC1 9 2R8 A 301 GOL A 305 HOH A 451 HOH A 457
SITE 3 BC1 9 HOH A 458
CRYST1 43.197 103.852 45.298 90.00 90.00 90.00 P 21 21 2 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.023150 0.000000 0.000000 0.00000
SCALE2 0.000000 0.009629 0.000000 0.00000
SCALE3 0.000000 0.000000 0.022076 0.00000